Adaptimmune to report q1 2024 financial and business updates on wednesday may 15 2024 – Artofit

Image gallery for: Adaptimmune to report q1 2024 financial and business updates on wednesday may 15 2024

Adaptimmune to Report Q1 2024 Financial and Business Updates on Wednesday, May 15, 2024

Philadelphia, Pennsylvania and Oxford, United Kindgom--(Newsfile Corp. - May 1, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company redefining...
Advertisement
Consumer Behaviour Playbook FREE Download

All about business
Golden Horse Identifies Lithium Anomaly at Southern Cross North Project

Newsfile Press Releases
Upcoming Course Dates

All about Project Management
Adaptimmune to Report Q3 2023 Financial and Business Updates on Wednesday, November 8, 2023

Newsfile Press Releases
Advertisement
CEO.CA's Inside The Boardroom: American Eagle Continues to Discover High-Grade Copper and Gold at NAK

Newsfile Press Releases
Awakn Life Sciences Receives Regulatory and Ethical Approval for Phase III Clinical Trial of AWKN-P001

Newsfile Press Releases
Telescope Innovations Reports Strong Growth in Fiscal Year 2023

Newsfile Press Releases
CORRECTION FROM SOURCE: Turnium Technology Group Inc. Reports Growth in Fiscal Q1 2024 Financial Results

Newsfile Press Releases
Adaptimmune to Report Q2 2024 Financial and Business Updates on Monday, August 12, 2024

Newsfile Press Releases
SRx Health Solutions Inc. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Newsfile Press Releases
Railtown AI Technologies Announces Participation in the EF Hutton Annual Global Conference

Newsfile Press Releases
Advertisement
Advertisement
Advertisement
InMed Appoints Dr. David G. Morgan, PhD, a Leading Alzheimer's Expert, to the Company's Scientific Advisory Board

Newsfile Press Releases